May 10th 2024
Public hospitals were significantly more likely to sustain access to unprofitable services following 340B Drug Pricing Program participation, while nonprofit hospitals were mostly unaffected, according to a recent study.
To Prevent the Next Pandemic, Fight Antiscience Beliefs, Hotez Says
November 7th 2021While low- and middle-income countries remain desperate for a COVID-19 vaccine, the United States has entered a dangerous new phase of the pandemic, where antivaccine forces are exporting their antiscience beliefs to other countries, according to a keynote speaker at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
Read More
Dr Carina Venter on the Gut Microbiome’s Role in Allergic Disease
November 7th 2021Carina Venter, PhD, RD, allergy specialist dietitian and associate professor in pediatric allergy and immunology at Children's Hospital Colorado and the University of Colorado, discusses the gut microbiome’s complex relationship with our immune system and diet diversity’s potential role in allergic disease and food allergy–related outcomes.
Watch
Patients With CTEPH Have Worse Baseline HRQOL Than Patients With IPAH
November 6th 2021At baseline, patients with chronic thromboembolic pulmonary hypertension (CTEPH) had worse health-related quality of life (HRQOL) than patients with idiopathic pulmonary arterial hypertension (IPAH), but over time the scores were similar.
Read More
More SMA Biomarkers Are Needed to Gauge Disease Progression, Therapy Response
October 21st 2021A review of current molecular and electrophysiological biomarkers in spinal muscular atrophy (SMA) concluded that more exploration is necessary to find noninvasive, yet accurate, measures of disease progression and therapy response.
Read More
Dr Don Sin on the Barriers to Precision Medicine for COPD
October 18th 2021There are several reasons as to why precision therapeutics have not taken off for chronic obstructive pulmonary disease (COPD) in the same way that they have for other diseases, said Don Sin, MD, FRCP, MPH, a professor of respiratory medicine at the University of British Columbia and head of the Centre of Heart Lung Innovation, St. Paul’s Hospital.
Watch
Patient Characteristics Impact Effectiveness of TKIs in CML and AEs Experienced
October 1st 2021Dosing from pivotal phase 3 trials of tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia (CML) is not optimal for real-world patients who experience different efficacy and adverse events (AEs).
Read More
Addressing Disparities Starts With Engaging the Community
September 24th 2021In the opening sessions at the Patient-Centered Oncology Care® conference, held September 23-24 both virtually and in Nashville, Tennessee, speakers focused on addressing disparities by getting involved and engaged with the community.
Read More
Reducing Disparities, Using AI, Improving Clinical Trials on Tap for PCOC 2021
September 17th 2021At the 10th anniversary meeting of Patient-Centered Oncology Care®, sessions will cover reducing disparities in cancer care, bringing clinical trials closer to the community, and expanding the scope of what the term "precision medicine" means in cancer care.
Read More
Could Psychedelics Ease Mental Health Toll From COVID-19, Other Crises?
September 15th 2021The fallout from COVID-19 has spotlighted the limitations of US mental health care, prompting the question if alternative treatments—like psychedelics—could help address current and impending crises.
Read More
The Green Environment, Air Pollution, and Respiratory Health
September 9th 2021Increasing air pollution and climate change have an impact on respiratory health and mortality, explained speakers in 2 sessions on the environment and respiratory diseases at the European Respiratory Society International Congress 2021.
Read More
Considering Sex and Gender Differences in Respiratory Health
September 7th 2021Health care and research need to do a better job of taking into account sex and gender differences that can affect disease, healthy behaviors, and care delivery, according to speakers at the European Respiratory Society International Congress 2021.
Read More
Disparities Persist in the Long Term for 5-Year AYA Survivors of Hodgkin Lymphoma
August 4th 2021Treatment-related modifications have resulted in improved long-term outcomes for all adolescent and young adult (AYA) survivors of Hodgkin lymphoma, but new research highlights that racial, ethnic, and socioeconomic status disparities persist in the long term.
Read More
Dr Ron Eccles Outlines the Challenges of the Placebo Effect for Cough Medicines
July 24th 2021Patients may find a placebo effect beneficial, but it causes issues in a clinical trial and makes it difficult to understand the efficacy of a pharmacological agent, said Ron Eccles, BSc, PhD, DSc, emeritus professor at Cardiff University.
Watch
NAFLD Increases Mortality in Children and Young Adults Over the Long Term
July 8th 2021A long-term Swedish study found that nonalcoholic fatty liver disease (NALFD) significantly increased mortality in children and young adults, particularly due to cancer, cardiometabolic disease, and liver disease.
Read More